Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
The RMR Group
RMR
$346M
| $118K | ﹤0.01% |
5,058
| – | – |
|
5102
Treace Medical Concepts
TMCI
$312M
| $118K | ﹤0.01% |
4,601
+2,362
| +105% | +$61K |
|
|
NDP
5103
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
| $118K | ﹤0.01% |
4,093
-710
| -15% | -$20.2K |
|
|
SRTA
5104
Strata Critical Medical Inc
SRTA
$522M
| $117K | ﹤0.01% |
29,705
+2,929
| +11% | +$9.29K |
|
5105
Invesco BulletShares 2031 Municipal Bond ETF
BSMV
$188M
| $117K | ﹤0.01% |
5,516
-3,107
| -36% | -$65.9K |
|
5106
Coherus Oncology
CHRS
$185M
| $117K | ﹤0.01% |
27,329
+677
| +3% | +$4K |
|
5107
Hyster-Yale Materials Handling
HY
$618M
| $117K | ﹤0.01% |
2,085
+703
| +51% | +$36K |
|
5108
OP Bancorp
OPBK
$233M
| $117K | ﹤0.01% |
13,927
-1,420
| -9% | -$12K |
|
5109
Travere Therapeutics
TVTX
$5.86B
| $117K | ﹤0.01% |
7,655
+1,732
| +29% | +$31.5K |
|
|
QUOT
5110
DELISTED
Quotient Technology Inc
QUOT
| $117K | ﹤0.01% |
30,449
+25,306
| +492% | +$78.5K |
|
5111
Aspen Aerogels
ASPN
$485M
| $116K | ﹤0.01% |
14,594
+2,064
| +16% | +$14.4K |
|
|
BRY
5112
DELISTED
Berry Corp
BRY
| $116K | ﹤0.01% |
16,787
+12,524
| +294% | +$90.2K |
|
5113
Chemung Financial Corp
CHMG
$405M
| $116K | ﹤0.01% |
3,029
+363
| +14% | +$13.8K |
|
|
EARN
5114
Ellington Residential Mortgage REIT
EARN
$165M
| $116K | ﹤0.01% |
16,169
-8,546
| -35% | -$60.7K |
|
5115
Gulfport Energy Corp
GPOR
$3.01B
| $116K | ﹤0.01% |
1,107
+350
| +46% | +$32.4K |
|
5116
Protagonist Therapeutics
PTGX
$10B
| $116K | ﹤0.01% |
4,217
+1,583
| +60% | +$39.6K |
|
5117
Scholastic
SCHL
$781M
| $116K | ﹤0.01% |
2,994
+1,344
| +81% | +$52.2K |
|
|
NKLA
5118
DELISTED
Nikola Corporation Common Stock
NKLA
| $116K | ﹤0.01% |
2,799
+1,058
| +61% | +$29.2K |
|
5119
Bally's
BALY
$685M
| $115K | ﹤0.01% |
7,448
+5,261
| +241% | +$84.8K |
|
5120
Barron's 400 ETF
BFOR
$239M
| $115K | ﹤0.01% |
8,000
-408
| -5% | -$5.5K |
|
5121
F&G Annuities & Life
FG
$3.59B
| $115K | ﹤0.01% |
4,654
-2,111
| -31% | -$41.4K |
|
5122
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$549M
| $115K | ﹤0.01% |
1,621
-18,877
| -92% | -$1.26M |
|
5123
Superior Group of Companies
SGC
$208M
| $115K | ﹤0.01% |
12,289
-13,091
| -52% | -$110K |
|
5124
Zegna
ZGN
$3.69B
| $115K | ﹤0.01% |
9,021
+4,772
| +112% | +$59.4K |
|
|
ALYA
5125
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $115K | ﹤0.01% |
70,560
+5,293
| +8% | +$9.77K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.